Abstract
Oral progestins have been the mainstay in hormone replacement therapy (HRT). However, their users have been plagued by bothersome side effects such as irritability, mood swings, bloating, and headache (1). These problems contribute to patients discontinuing HRT, thus denying them its long-term benefits. The health care community continues to search for clinically effective alternative progestins. Investigators have been skeptical of the clinical utility of topical progesterone cream (PC) (2). However, our placebo-controlled study demonstrated that patients experienced improvement in vasomotor symptoms through the use of PC (3). This systemic finding suggests a possible role for topical PC on the endometrium as well. To this end, we designed a randomized, double-masked, placebo-controlled study for postmenopausal women.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
